Geneva: The World Health Organization (WHO) has unveiled comprehensive updates to its influenza care guidelines, reflecting the latest medical advancements and public health strategies. These revisions aim to improve prevention, diagnosis, and treatment, particularly in light of lessons learned from the COVID-19 pandemic.
A multidisciplinary Guideline Development Group, consisting of content experts, clinicians, patients, ethicists, and methodologists, reviewed the available data to create these recommendations. They followed established standards for reliable guideline development, utilizing the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology.
Influenza is a global viral disease, causing around a billion cases annually, including 3–5 million severe respiratory illnesses and 290,000–650,000 deaths. Animal influenza viruses, like avian and swine flu, can occasionally infect humans and pose a future pandemic threat.
The updated guidelines recommend antiviral treatments and steroids for seasonal influenza, potential pandemic strains, and new type A viruses that cause severe illness. Some important updates are;
Prioritizing vaccination
The updated guidelines place a stronger emphasis on vaccination, particularly for vulnerable populations such as the elderly, pregnant women, healthcare workers, and individuals with chronic illnesses. WHO recommends scaling up vaccination campaigns globally, especially in low- and middle-income countries where access remains limited.
Enhanced access to antivirals and diagnostics
The WHO also highlighted the need for better access to antiviral medications. The guidelines call for countries to strengthen supply chains for antiviral drugs like Oseltamivir (Tamiflu) and Baloxavir, ensuring timely treatment for those infected.
The WHO urges countries to invest in faster and more accessible diagnostic testing, allowing for early identification and management of influenza outbreaks. These steps are vital to improving outcomes, especially during seasonal flu peaks.
Learning from COVID-19
One of the key elements of the updated guidelines is the incorporation of lessons learned from the COVID-19 pandemic. The WHO recommends enhancing influenza surveillance systems, boosting healthcare infrastructure, and reinforcing the use of personal protective equipment (PPE) among healthcare workers.
Public awareness and preventive measures
The WHO is also advocating for stronger public health campaigns to raise awareness about preventive measures, such as hand hygiene, mask-wearing, and the importance of annual flu vaccinations. These measures, often underutilized, can play a critical role in reducing transmission rates.
Global collaboration
WHO officials reiterated the need for international cooperation in combating influenza. With seasonal flu claiming hundreds of thousands of lives annually, the organization stressed that no country can fight this battle alone.
The recommendations are part of the WHO’s comprehensive response to influenza, which includes the Global Influenza Surveillance and Response System (GISRS) and the Pandemic Influenza Preparedness (PIP) framework. These initiatives aim to address gaps in access to effective medical treatments and other resources. The revised guidelines come ahead of flu season in several regions and serve as a critical tool for nations to enhance their readiness and response capabilities.
YOU MAY LIKE | Beijing opens 2024 CIFTIS, boosting global trade opportunities
